-15% New

TAK-653 (Osavampator) 2 mg – 60 tablets

Original price was: 64,20 €.Current price is: 54,57 €.

42 in stock

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Product Description

Research Compound · Tablets

TAK-653 (Osavampator) 2 mg – 60 Tablets

Research-grade compound supplied as 60 pre-portioned tablets, each containing 2 mg TAK-653 (osavampator). A selective, non-desensitizing AMPA-receptor positive allosteric modulator (PAM) studied in controlled experimental models of glutamatergic signaling, synaptic plasticity, and rapid-acting antidepressant pharmacology.

Research Use Only

This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity

≥99% (HPLC, third-party tested, CoA on file)

Form

Research tablets

Content per Tablet

2 mg TAK-653 (osavampator)

Total per Bottle

60 tablets (120 mg total)

Packaging

Sealed bottle with tamper-evident closure

Storage

Store at room temperature, dry, protected from light

Molecular Formula

C₁₉H₂₃N₃O₃S

Molecular Weight

≈ 373.47 g/mol

Synonyms

TAK-653; Osavampator; NBI-1065845

CAS Number

1358751-06-0

Format

Supplied as pre-portioned research tablets — no reconstitution or weighing is required, supporting consistent dosing accuracy in controlled experimental workflows. Keep the bottle sealed and stored at room temperature, dry and protected from light.

Research Overview

TAK-653 is a selective, non-desensitizing positive allosteric modulator of the AMPA subtype of ionotropic glutamate receptors, the principal mediator of fast excitatory neurotransmission in the mammalian brain. Unlike older AMPA potentiators, it was engineered to minimize agonistic activity while enhancing synaptic AMPA signaling in physiologically relevant ranges. In controlled experimental settings it is used as a reference compound for glutamatergic plasticity, cognition, and rapid-acting antidepressant mechanism research. No therapeutic or clinical claims are made or implied.